Review





Similar Products

96
Proteintech ub 10 201 2 ap
Ub 10 201 2 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mfn1+2/MFN1+Antibody/pm41795472-157-60-66
Average 96 stars, based on 1 article reviews
ub 10 201 2 ap - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc anti targeting mfn1/2
Anti Targeting Mfn1/2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mfn1+2/pm40816649-54-0-17
Average 86 stars, based on 1 article reviews
anti targeting mfn1/2 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc mfn1
Mfn1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mfn1+2/Mitofusin-2+Rabbit+mAb/pmc11996814-93-52-58
Average 95 stars, based on 1 article reviews
mfn1 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

90
Mitochon Pharmaceuticals mitochondrial fusion proteins mfn1 and 2 and opa1
Mitochondrial Fusion Proteins Mfn1 And 2 And Opa1, supplied by Mitochon Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mfn1+2/opa1+protein/pm39749698-176-9-9
Average 90 stars, based on 1 article reviews
mitochondrial fusion proteins mfn1 and 2 and opa1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc rabbit anti mfn1
Rabbit Anti Mfn1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mfn1+2/Mitofusin-2+Rabbit+mAb/pmc11318672-164-17-20
Average 95 stars, based on 1 article reviews
rabbit anti mfn1 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc mfn1/2 antibodies
Mfn1/2 Antibodies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mfn1+2/anti+p38/pmc11318672__JCB_202304031_review_history-202-12-16
Average 90 stars, based on 1 article reviews
mfn1/2 antibodies - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mfn1 2
Mfn1 2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mfn1+2/Mfn1+Antibody/pmc11429207-53-8-14
Average 96 stars, based on 1 article reviews
mfn1 2 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
Thermo Fisher sirna mfn1 #2
Mitochondrial fusion is dispensable for cell proliferation (A) Western blotting of PANC-1 cells treated with non-targeting control or two different <t>MFN1</t> siRNAs for 5 days. An arrow and an asterisk indicate MFN1 and non-specific bands, respectively. (B) Quantification of band intensity (mean ± SD, n = 3). (C) PANC-1 cells were transfected with the indicated siRNAs and subjected to laser confocal immunofluorescence microscopy with anti-PDH antibodies. The boxed regions are magnified. (D) Cell proliferation of the transfectants was examined by a crystal violet assay (mean ± SD, n = 5). (E) PANC-1 cells were infected with lentiviruses expressing scramble or DRP1 shRNAs and then treated with DMSO or MYLS22 for 24 h. Knockdown of DRP1 was confirmed by Western blotting. (F) Quantification of band intensity (mean ± SD, n = 3). (G) Mitochondria were analyzed by immunofluorescence microscopy with anti-TOM20 antibodies. (H) Cell proliferation was analyzed by a crystal violet assay (mean ± SD, n = 5). ANOVA with post-hoc Tukey in (B, D, F, H): ∗ p < 0.05, ∗∗∗ p < 0.01, ∗∗∗ p < 0.001.
Sirna Mfn1 #2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mfn1+2/igg+isotype+control/pmc11416656-88-0-4
Average 90 stars, based on 1 article reviews
sirna mfn1 #2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Thermo Fisher mfn1 #2 (s31220)

Mfn1 #2 (S31220), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mfn1+2/pmc11416656-323-18-6
Average 90 stars, based on 1 article reviews
mfn1 #2 (s31220) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Thermo Fisher sirna: mfn1 #2
Mitochondrial fusion is dispensable for cell proliferation (A) Western blotting of PANC-1 cells treated with non-targeting control or two different <t>MFN1</t> siRNAs for 5 days. An arrow and an asterisk indicate MFN1 and non-specific bands, respectively. (B) Quantification of band intensity (mean ± SD, n = 3). (C) PANC-1 cells were transfected with the indicated siRNAs and subjected to laser confocal immunofluorescence microscopy with anti-PDH antibodies. The boxed regions are magnified. (D) Cell proliferation of the transfectants was examined by a crystal violet assay (mean ± SD, n = 5). (E) PANC-1 cells were infected with lentiviruses expressing scramble or DRP1 shRNAs and then treated with DMSO or MYLS22 for 24 h. Knockdown of DRP1 was confirmed by Western blotting. (F) Quantification of band intensity (mean ± SD, n = 3). (G) Mitochondria were analyzed by immunofluorescence microscopy with anti-TOM20 antibodies. (H) Cell proliferation was analyzed by a crystal violet assay (mean ± SD, n = 5). ANOVA with post-hoc Tukey in (B, D, F, H): ∗ p < 0.05, ∗∗∗ p < 0.01, ∗∗∗ p < 0.001.
Sirna: Mfn1 #2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mfn1+2/igg+isotype+control/pmc11416656-89-0-4
Average 90 stars, based on 1 article reviews
sirna: mfn1 #2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Mitochondrial fusion is dispensable for cell proliferation (A) Western blotting of PANC-1 cells treated with non-targeting control or two different MFN1 siRNAs for 5 days. An arrow and an asterisk indicate MFN1 and non-specific bands, respectively. (B) Quantification of band intensity (mean ± SD, n = 3). (C) PANC-1 cells were transfected with the indicated siRNAs and subjected to laser confocal immunofluorescence microscopy with anti-PDH antibodies. The boxed regions are magnified. (D) Cell proliferation of the transfectants was examined by a crystal violet assay (mean ± SD, n = 5). (E) PANC-1 cells were infected with lentiviruses expressing scramble or DRP1 shRNAs and then treated with DMSO or MYLS22 for 24 h. Knockdown of DRP1 was confirmed by Western blotting. (F) Quantification of band intensity (mean ± SD, n = 3). (G) Mitochondria were analyzed by immunofluorescence microscopy with anti-TOM20 antibodies. (H) Cell proliferation was analyzed by a crystal violet assay (mean ± SD, n = 5). ANOVA with post-hoc Tukey in (B, D, F, H): ∗ p < 0.05, ∗∗∗ p < 0.01, ∗∗∗ p < 0.001.

Journal: iScience

Article Title: Mitochondria-targeted cancer analysis using survival and expression: Prioritizing mitochondrial targets that alleviate pancreatic cancer cell phenotypes

doi: 10.1016/j.isci.2024.110880

Figure Lengend Snippet: Mitochondrial fusion is dispensable for cell proliferation (A) Western blotting of PANC-1 cells treated with non-targeting control or two different MFN1 siRNAs for 5 days. An arrow and an asterisk indicate MFN1 and non-specific bands, respectively. (B) Quantification of band intensity (mean ± SD, n = 3). (C) PANC-1 cells were transfected with the indicated siRNAs and subjected to laser confocal immunofluorescence microscopy with anti-PDH antibodies. The boxed regions are magnified. (D) Cell proliferation of the transfectants was examined by a crystal violet assay (mean ± SD, n = 5). (E) PANC-1 cells were infected with lentiviruses expressing scramble or DRP1 shRNAs and then treated with DMSO or MYLS22 for 24 h. Knockdown of DRP1 was confirmed by Western blotting. (F) Quantification of band intensity (mean ± SD, n = 3). (G) Mitochondria were analyzed by immunofluorescence microscopy with anti-TOM20 antibodies. (H) Cell proliferation was analyzed by a crystal violet assay (mean ± SD, n = 5). ANOVA with post-hoc Tukey in (B, D, F, H): ∗ p < 0.05, ∗∗∗ p < 0.01, ∗∗∗ p < 0.001.

Article Snippet: siRNA: MFN1 #1 , Thermo Fisher Scientific , Assay ID: s31218.

Techniques: Western Blot, Control, Transfection, Immunofluorescence, Microscopy, Crystal Violet Assay, Infection, Expressing, Knockdown

Journal: iScience

Article Title: Mitochondria-targeted cancer analysis using survival and expression: Prioritizing mitochondrial targets that alleviate pancreatic cancer cell phenotypes

doi: 10.1016/j.isci.2024.110880

Figure Lengend Snippet:

Article Snippet: siRNA: MFN1 #1 , Thermo Fisher Scientific , Assay ID: s31218.

Techniques: Recombinant, Modification, Ligation, Transfection, Infection, Electron Microscopy, Protease Inhibitor, Negative Control, shRNA, Sequencing, Plasmid Preparation, Software

Journal: iScience

Article Title: Mitochondria-targeted cancer analysis using survival and expression: Prioritizing mitochondrial targets that alleviate pancreatic cancer cell phenotypes

doi: 10.1016/j.isci.2024.110880

Figure Lengend Snippet:

Article Snippet: The following Silencer Select siRNAs from Thermo Fisher were used: negative control (4390843), MFN1 #1 (s31218), MFN1 #2 (s31220), MIC60 #1 (s21633), and MIC60 #2 (s21634).

Techniques: Recombinant, Modification, Ligation, Transfection, Infection, Electron Microscopy, Protease Inhibitor, Negative Control, shRNA, Sequencing, Plasmid Preparation, Software

Mitochondrial fusion is dispensable for cell proliferation (A) Western blotting of PANC-1 cells treated with non-targeting control or two different MFN1 siRNAs for 5 days. An arrow and an asterisk indicate MFN1 and non-specific bands, respectively. (B) Quantification of band intensity (mean ± SD, n = 3). (C) PANC-1 cells were transfected with the indicated siRNAs and subjected to laser confocal immunofluorescence microscopy with anti-PDH antibodies. The boxed regions are magnified. (D) Cell proliferation of the transfectants was examined by a crystal violet assay (mean ± SD, n = 5). (E) PANC-1 cells were infected with lentiviruses expressing scramble or DRP1 shRNAs and then treated with DMSO or MYLS22 for 24 h. Knockdown of DRP1 was confirmed by Western blotting. (F) Quantification of band intensity (mean ± SD, n = 3). (G) Mitochondria were analyzed by immunofluorescence microscopy with anti-TOM20 antibodies. (H) Cell proliferation was analyzed by a crystal violet assay (mean ± SD, n = 5). ANOVA with post-hoc Tukey in (B, D, F, H): ∗ p < 0.05, ∗∗∗ p < 0.01, ∗∗∗ p < 0.001.

Journal: iScience

Article Title: Mitochondria-targeted cancer analysis using survival and expression: Prioritizing mitochondrial targets that alleviate pancreatic cancer cell phenotypes

doi: 10.1016/j.isci.2024.110880

Figure Lengend Snippet: Mitochondrial fusion is dispensable for cell proliferation (A) Western blotting of PANC-1 cells treated with non-targeting control or two different MFN1 siRNAs for 5 days. An arrow and an asterisk indicate MFN1 and non-specific bands, respectively. (B) Quantification of band intensity (mean ± SD, n = 3). (C) PANC-1 cells were transfected with the indicated siRNAs and subjected to laser confocal immunofluorescence microscopy with anti-PDH antibodies. The boxed regions are magnified. (D) Cell proliferation of the transfectants was examined by a crystal violet assay (mean ± SD, n = 5). (E) PANC-1 cells were infected with lentiviruses expressing scramble or DRP1 shRNAs and then treated with DMSO or MYLS22 for 24 h. Knockdown of DRP1 was confirmed by Western blotting. (F) Quantification of band intensity (mean ± SD, n = 3). (G) Mitochondria were analyzed by immunofluorescence microscopy with anti-TOM20 antibodies. (H) Cell proliferation was analyzed by a crystal violet assay (mean ± SD, n = 5). ANOVA with post-hoc Tukey in (B, D, F, H): ∗ p < 0.05, ∗∗∗ p < 0.01, ∗∗∗ p < 0.001.

Article Snippet: siRNA: MFN1 #2 , Thermo Fisher Scientific , Assay ID: s31220.

Techniques: Western Blot, Control, Transfection, Immunofluorescence, Microscopy, Crystal Violet Assay, Infection, Expressing, Knockdown

Journal: iScience

Article Title: Mitochondria-targeted cancer analysis using survival and expression: Prioritizing mitochondrial targets that alleviate pancreatic cancer cell phenotypes

doi: 10.1016/j.isci.2024.110880

Figure Lengend Snippet:

Article Snippet: siRNA: MFN1 #2 , Thermo Fisher Scientific , Assay ID: s31220.

Techniques: Recombinant, Modification, Ligation, Transfection, Infection, Electron Microscopy, Protease Inhibitor, Negative Control, shRNA, Sequencing, Plasmid Preparation, Software